Institutional investors hold a majority ownership of MYL through the 90.48% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended September 2014, these large investors purchased a net $2.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 3.9 Million shares of Mylan Inc
PAULSON & CO., INC. Bought 2.5 Million shares of Mylan Inc
GOLDMAN SACHS & CO. (PRIVATE BAN... Bought 2.4 Million shares of Mylan Inc